Key result
Supervised exercise training for 12 weeks significantly improved maximal walking distance by 91% in patients with peripheral atherosclerotic disease, with no changes in peak cardiovascular measures.
Why the study?
Does supervised exercise improve maximal walking time and cardiovascular function in patients with peripheral atherosclerotic disease?
RCT (n=28)
Does supervised exercise improve maximal walking time and cardiovascular function in patients with peripheral atherosclerotic disease?
A 12-week supervised exercise program significantly improves maximal walking distance in patients with PAD, allowing them to complete higher workloads for equivalent circulatory demands.
Supervised exercise improves walking tolerance in PAD without altering peak CV parameters; challenges cardiac adaptations as the main mechanism.
INTRODUCTION: Peripheral atherosclerotic disease (PAD) is a condition characterized by low functional capacity which is associated with impaired free living, ambulation and low exercise tolerance. The purpose of this randomized controlled study was to evaluate whether changes in maximal walking time are associated with adaptations in cardiovascular function following supervised exercise. METHODS: After ethics approval, 28 patients (63 +/- 11 years) completed a graded treadmill test (2 min stages, 3.2 km h(-1), with gradient increasing 2% every 2 min) until they reached level three or four on the claudication pain scale. Peak oxygen consumption was assessed on a breath-by-breath basis, by online expiratory gas analysis. Following a 40-min recovery period, peak cardiac output was measured using the non-invasive carbon dioxide rebreathing method described by Defares (J Appl Physiol, 13, 1958, 159). Peak cardiac power output was then computed using the equation described by Cooke et al. (Heart, 1998, 79, 289). Patients were randomly assigned to one of two groups: supervised, who exercised at the hospital twice weekly for 12 weeks or control, who received normal treatment which included encouragement to walk regularly. RESULTS: After 12 weeks, there were no significant changes in body mass, peak oxygen consumption, peak cardiac output, peak heart rate, peak cardiac power output, respiratory exchange ratio or rating of perceived exertion in both the supervised and control group. There was a significant improvement (91%) in maximal walking distance following the supervised exercise programme. Although patients' peak cardiovascular measurements were unchanged, the patients in the supervised exercise group were able to complete a higher workload at the end of the 12 weeks of exercise, for the equivalent demands on the circulation system. CONCLUSIONS: The findings from this study suggest that a short-term period of supervised exercise training results in an improved walking time in patients with limiting claudication because of PAD. It also demonstrated that the cardiovascular system becomes more efficient in meeting the demands of exercise. It is recommended that individuals with PAD should undertake exercise as a form of treatment.
No takes yet. Share an insight, caveat, or question.
Hodges et al. (2007) conducted an RCT in Peripheral atherosclerotic disease (PAD) (n=28). Supervised exercise vs. Normal treatment (encouragement to walk regularly) was evaluated on Maximal walking distance and peak cardiovascular measurements. Supervised exercise training for 12 weeks significantly improved maximal walking distance by 91% in patients with peripheral atherosclerotic disease, with no changes in peak cardiovascular measures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: